Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Virchows Archiv : an International Journal of Pathology|July 19, 2024
Digital volumetric assessment of CIS and tumor mass compliments conventional histopathological assessment in muscle-invasive urothelial bladder cancerFabienne Lange, Carol I Geppert, Veronika Bahlinger, et al.
Molecular Cancer Research : MCR|April 1, 2010
The microRNA profile of prostate carcinoma obtained by deep sequencingJaroslaw Szczyrba, Elke Löprich, Sven Wach, et al.
Scientific Reports|December 8, 2018
Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patientsMarkus Eckstein, Rudolf Jung, Katrin Weigelt, et al.
Andrology|December 17, 2025
Histopathological Characterization and Differential Expression of miRNAs in Male Pediatric Patients With Lichen SclerosusValerie Flammang, Arndt Hartmann, Robert Stöhr, et al.
The Journal of Molecular Diagnostics : JMD|April 5, 2026
Oncogenicity Variant Interpreter (OncoVI): oncogenicity guidelines implementation to support somatic variants interpretation in precision oncologyMaria Giulia Carta, Lars Tögel, Annett Hölsken, et al.
Cancer Research|December 18, 2012
Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesisFilip Roudnicky, Cedric Poyet, Peter Wild, et al.
Cancers|October 2, 2020
Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with PrognosisJennifer Kubon, Danijel Sikic, Markus Eckstein, et al.
Neoplasia (New York, N.Y.)|August 7, 2010
MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapyAndreas-Claudius Hoffmann, Peter Wild, Christina Leicht, et al.
Virchows Archiv : an International Journal of Pathology|February 12, 2021
Eosinophilic cystitis mimicking bladder cancer-considerations on the management based upon a case report and a review of the literatureBernd J Schmitz-Dräger, Andreas Skutetzki, Ralf J Rieker, et al.
Scientific Reports|September 28, 2018
CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-makingThomas S Worst, Cleo-Aron Weis, Robert Stöhr, et al.
Pageof 9